Kangmei Pharma | 600518 - Ebitda

Stock Price
1.91
Daily Change
0.02 1.06%
Monthly
-0.52%
Yearly
-14.35%
Q1 Forecast
1.86

Kangmei Pharma reported CNY17.3M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Avita Medical AUD -21.9M 12.04M Jun/2025
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Genomma Lab Internacional MXN 843.15M 175.14M Jun/2025
Hypermarcas BRL 756.2M 9.72M Sep/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
IQVIA Holdings USD 949M 39M Sep/2025
Jiangsu Hengrui CNY 2.98B 890.87M Jun/2025
Kangmei Pharma CNY 17.3M 20.56M Jun/2025
Moderna USD -208M 552M Sep/2025
Organon & Co USD 518M 4M Sep/2025
Revvity USD 248.91M 48.52M Dec/2025
Sh Fosun Pharma CNY 1.69B 17.13M Jun/2025
Tectonic Therapeutic USD -13.48M 5.73M Dec/2024
Viatris USD 1.15B 75.8M Sep/2025
WuXi AppTec CNY 5.71B 1.36B Jun/2025
Xeris Pharmaceuticals USD 17.42M 8.83M Sep/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M Jun/2025